1. Home
  2. OPP vs MGRM Comparison

OPP vs MGRM Comparison

Compare OPP & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPP
  • MGRM
  • Stock Information
  • Founded
  • OPP 2010
  • MGRM 2016
  • Country
  • OPP United States
  • MGRM United States
  • Employees
  • OPP N/A
  • MGRM N/A
  • Industry
  • OPP Finance/Investors Services
  • MGRM Medical/Dental Instruments
  • Sector
  • OPP Finance
  • MGRM Health Care
  • Exchange
  • OPP Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • OPP 208.6M
  • MGRM 232.0M
  • IPO Year
  • OPP N/A
  • MGRM N/A
  • Fundamental
  • Price
  • OPP $8.78
  • MGRM $5.75
  • Analyst Decision
  • OPP
  • MGRM Strong Buy
  • Analyst Count
  • OPP 0
  • MGRM 1
  • Target Price
  • OPP N/A
  • MGRM $5.40
  • AVG Volume (30 Days)
  • OPP 108.0K
  • MGRM 95.4K
  • Earning Date
  • OPP 01-01-0001
  • MGRM 08-15-2025
  • Dividend Yield
  • OPP 14.41%
  • MGRM N/A
  • EPS Growth
  • OPP N/A
  • MGRM N/A
  • EPS
  • OPP N/A
  • MGRM N/A
  • Revenue
  • OPP N/A
  • MGRM N/A
  • Revenue This Year
  • OPP N/A
  • MGRM N/A
  • Revenue Next Year
  • OPP N/A
  • MGRM N/A
  • P/E Ratio
  • OPP N/A
  • MGRM N/A
  • Revenue Growth
  • OPP N/A
  • MGRM N/A
  • 52 Week Low
  • OPP $7.26
  • MGRM $1.92
  • 52 Week High
  • OPP $8.83
  • MGRM $6.02
  • Technical
  • Relative Strength Index (RSI)
  • OPP 66.05
  • MGRM 59.62
  • Support Level
  • OPP $8.70
  • MGRM $5.67
  • Resistance Level
  • OPP $8.78
  • MGRM $5.89
  • Average True Range (ATR)
  • OPP 0.07
  • MGRM 0.16
  • MACD
  • OPP 0.01
  • MGRM -0.03
  • Stochastic Oscillator
  • OPP 87.32
  • MGRM 60.24

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: